ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 171 filers reported holding ICU MED INC in Q3 2013. The put-call ratio across all filers is 2.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $242,304 | -61.4% | 2,036 | -42.1% | 0.01% | -61.9% |
Q2 2023 | $627,051 | +282355.4% | 3,519 | +161.6% | 0.02% | +200.0% |
Q1 2023 | $222 | +241.5% | 1,345 | +227.3% | 0.01% | +133.3% |
Q4 2022 | $65 | -100.0% | 411 | -76.3% | 0.00% | -25.0% |
Q3 2022 | $261,000 | -79.8% | 1,734 | -77.9% | 0.00% | -86.2% |
Q2 2022 | $1,290,000 | +29.4% | 7,845 | +75.2% | 0.03% | +190.0% |
Q1 2022 | $997,000 | +113.5% | 4,479 | +127.4% | 0.01% | +25.0% |
Q4 2021 | $467,000 | +47.8% | 1,970 | +45.5% | 0.01% | 0.0% |
Q3 2021 | $316,000 | +20.2% | 1,354 | +5.9% | 0.01% | +14.3% |
Q2 2021 | $263,000 | +26.4% | 1,278 | +26.0% | 0.01% | +75.0% |
Q1 2021 | $208,000 | -82.1% | 1,014 | -81.3% | 0.00% | -88.6% |
Q4 2020 | $1,160,000 | -9.3% | 5,410 | -22.7% | 0.04% | +150.0% |
Q3 2020 | $1,279,000 | +31.6% | 6,997 | +32.7% | 0.01% | -65.0% |
Q2 2020 | $972,000 | +2109.1% | 5,273 | +2296.8% | 0.04% | +1233.3% |
Q1 2020 | $44,000 | -77.8% | 220 | -79.2% | 0.00% | -81.2% |
Q4 2019 | $198,000 | +1314.3% | 1,057 | +1129.1% | 0.02% | +1500.0% |
Q3 2019 | $14,000 | -78.5% | 86 | -66.7% | 0.00% | -75.0% |
Q2 2019 | $65,000 | -57.2% | 258 | -59.2% | 0.00% | -55.6% |
Q1 2019 | $152,000 | +289.7% | 632 | +274.0% | 0.01% | +200.0% |
Q4 2018 | $39,000 | -91.3% | 169 | -89.3% | 0.00% | -90.9% |
Q3 2018 | $447,000 | +794.0% | 1,579 | +828.8% | 0.03% | +1000.0% |
Q2 2018 | $50,000 | -61.2% | 170 | -66.8% | 0.00% | -72.7% |
Q1 2018 | $129,000 | -65.5% | 512 | -74.5% | 0.01% | -64.5% |
Q3 2017 | $374,000 | +2776.9% | 2,010 | +2237.2% | 0.03% | +3000.0% |
Q1 2017 | $13,000 | -45.8% | 86 | -46.6% | 0.00% | -66.7% |
Q4 2016 | $24,000 | -80.6% | 161 | -85.4% | 0.00% | -75.0% |
Q2 2016 | $124,000 | +226.3% | 1,102 | +168.8% | 0.01% | +140.0% |
Q1 2015 | $38,000 | +3700.0% | 410 | +4455.6% | 0.01% | – |
Q4 2014 | $1,000 | -99.1% | 9 | -99.5% | 0.00% | -100.0% |
Q3 2014 | $109,000 | +890.9% | 1,691 | +877.5% | 0.01% | +1100.0% |
Q2 2014 | $11,000 | -38.9% | 173 | -41.9% | 0.00% | -50.0% |
Q1 2014 | $18,000 | -80.9% | 298 | -78.6% | 0.00% | -80.0% |
Q3 2013 | $94,000 | +248.1% | 1,394 | +270.7% | 0.01% | +400.0% |
Q2 2013 | $27,000 | – | 376 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EVR Research LP | 22,000 | $4,719,000 | 3.86% |
NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |